Albertsons Records Anemic Comps as It Faces Pharmacy Headwinds

Albertsons records anemic comps as it faces pharmacy headwinds

The grocer saw identical sales growth of less than 1% in Q4 and recorded a $480 million net loss that reflects the cost of a deal to settle opioid-related claims.

Albertsons Q4 underscores pharmacy pressure

BOISE, Idaho — Albertsons Companies reported fourth-quarter results that highlighted ongoing pressure in pharmacy operations, while also announcing a major opioid settlement framework and a dividend increase that signals confidence in long-term cash flow.For the fourth quarter ended Feb. 28, Albertsons reported identical sales growth of 0.7%, with pharmacy remaining a key driver but also a source of volatility amid pricing pressures and reimburs…

Albertsons® Companies Announces National Opioid Settlement Framework

BOISE, Idaho--(BUSINESS WIRE)--Albertsons® Companies, Inc. (NYSE: ACI) today announced it has reached a $774 million settlement framework to resolve substantially all of the opioid-related claims brought against the Company by state, local and tribal government entities nationally, if all conditions are satisfied. This settlement framework marks a significant step toward resolving opioid-related litigation, and Albertsons more... The post Albert…

Albertsons Q4, FY2025 report shows loss from opioid settlement

April 14, 2026 BOISE, Idaho–(BUSINESS WIRE)–Albertsons Companies, Inc. BB #:193326 today reported results for the fourth quarter of fiscal 2025 and full year fiscal 2025, which ended Feb. 28, 2026 and included 13 and 53 weeks, respectively. Fourth Quarter of Fiscal 2025 Highlights Identical sales increased 0.7% Digital sales increased 16% Loyalty members increased 12% to 51.2 million Net loss of $(481) million, or $(0.94) per share, inclusive o…